[Long-term effect of botulinum toxin type A injection on hypertrophic acne scar].

中华整形外科杂志 Pub Date : 2016-11-01
{"title":"[Long-term effect of botulinum toxin type A injection on hypertrophic acne scar].","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate both the short-and long-term effect of botulinum toxin type A (BTXA) injection on hypertrophic ache scar.</p><p><strong>Methods: </strong>A total of 26 patients with acne scar received BTXA injection of within 100 units. The effect was evaluated using the ECCA grading scale before treatment and during clinic re-visit, which based on history of acne scar and number of scar area.The short-and long-term effect was recorded. The average follow-up period was 39.23 months. All results were evaluated by SPSS 21.0.ANOVA was used to evaluate average value and standard deviation of ECCA grading scale. Kaplan-Meier survival curve was used to evaluate relapse-free period, and Pearson test was used to detect relevant factors of relapse-free period.</p><p><p>Results The BTXA injection showed significant positive long-term effect on inflammatory or hypertrophic acne scar. The average ECCA grading scale was 103.460 ±36.872 before treatment,79.620 ±37.146 at 6 months after treatment,63.160 ±24.049 at 12 months after treatment,47.500 ±4.629 at 18 months after treatment, and 50.000 ± 0.000 at 24 months after treatment,showing significant differences between any of two groups (P < 0.01).Average relapse free period was 28.354 ± 1.775 months. Relapse-free period was related to ECCA grading scale pre treatment and injection times (P < 0.01); meanwhile, dose of BTXA and length of disease all had statistical significance (P < 0.05); however, age and gender had no statistical significance (P > 0.05).</p><p><strong>Conclusions: </strong>The BTXA injection can relieve inflammation and improve scar texture in patients with hypertrophic acne scar in both the short-and long-term follow-up.</p>","PeriodicalId":69147,"journal":{"name":"中华整形外科杂志","volume":"32 6","pages":"432-7"},"PeriodicalIF":0.0000,"publicationDate":"2016-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华整形外科杂志","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To investigate both the short-and long-term effect of botulinum toxin type A (BTXA) injection on hypertrophic ache scar.

Methods: A total of 26 patients with acne scar received BTXA injection of within 100 units. The effect was evaluated using the ECCA grading scale before treatment and during clinic re-visit, which based on history of acne scar and number of scar area.The short-and long-term effect was recorded. The average follow-up period was 39.23 months. All results were evaluated by SPSS 21.0.ANOVA was used to evaluate average value and standard deviation of ECCA grading scale. Kaplan-Meier survival curve was used to evaluate relapse-free period, and Pearson test was used to detect relevant factors of relapse-free period.

Results The BTXA injection showed significant positive long-term effect on inflammatory or hypertrophic acne scar. The average ECCA grading scale was 103.460 ±36.872 before treatment,79.620 ±37.146 at 6 months after treatment,63.160 ±24.049 at 12 months after treatment,47.500 ±4.629 at 18 months after treatment, and 50.000 ± 0.000 at 24 months after treatment,showing significant differences between any of two groups (P < 0.01).Average relapse free period was 28.354 ± 1.775 months. Relapse-free period was related to ECCA grading scale pre treatment and injection times (P < 0.01); meanwhile, dose of BTXA and length of disease all had statistical significance (P < 0.05); however, age and gender had no statistical significance (P > 0.05).

Conclusions: The BTXA injection can relieve inflammation and improve scar texture in patients with hypertrophic acne scar in both the short-and long-term follow-up.

A型肉毒毒素注射治疗增生性痤疮疤痕的远期疗效观察
目的:探讨A型肉毒毒素(BTXA)注射液治疗增生性疼痛瘢痕的近期和远期疗效。方法:对26例痤疮瘢痕患者给予100单位以内的肉毒毒素注射。以痤疮疤痕史和疤痕面积数为基础,在治疗前和复诊时采用ECCA评分量表评价疗效。记录短期和长期效果。平均随访39.23个月。所有结果均采用SPSS 21.0进行评价。采用方差分析(ANOVA)评价ECCA分级量表的平均值和标准差。采用Kaplan-Meier生存曲线评价无复发期,Pearson检验检测无复发期的相关因素。结果BTXA注射液对炎性、增生性痤疮瘢痕有显著的远期疗效。治疗前ECCA评分平均为103.460±36.872分,治疗后6个月为79.620±37.146分,治疗后12个月为63.160±24.049分,治疗后18个月为47.500±4.629分,治疗后24个月为50.000±0.000分,两组比较差异均有统计学意义(P < 0.01)。平均无复发期为28.354±1.775个月。无复发时间与预处理前ECCA分级量表及注射次数有关(P < 0.01);同时,肉毒毒素剂量、病程均有统计学意义(P < 0.05);年龄、性别差异无统计学意义(P > 0.05)。结论:在增生性痤疮瘢痕患者的短期和长期随访中,肉毒毒素注射液均能缓解炎症,改善瘢痕质地。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
5346
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信